Psychological, Biological Responses to Social Stressors ID'd in Hormonal Contraceptive Users
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 4, 2024 -- Hormonal contraceptive (HC) use affects women's glucocorticoid, inflammatory, and psychological responses to psychosocial stress, which may contribute to observed differences in mental and physical health, according to a study published in the January issue of Brain, Behavior, and Immunity.
Noting that women using HCs exhibit numerous signs of chronic inflammation, but often have similar circulating proinflammatory cytokine levels, Summer Mengelkoch, Ph.D., from the University of California, Los Angeles, and colleagues examined women's glucocorticoid, inflammatory, and psychological responses to the Trier Social Stress Test (TSST) in 67 naturally cycling (NC) and 60 oral HC-using women.
The researchers found that the HC users and NC women had different glucocorticoid and proinflammatory cytokine responses to the TSST. TSST-induced increases in glucocorticoids were uncommon for NC women, and increases in glucocorticoids were accompanied by interleukin-6 elevations. However, increases in glucocorticoids in response to the TSST were common for women using HC, and increases in glucocorticoids were accompanied by tumor necrosis factor-α increases. Differences were also seen in the psychological responses to the TSST, with elevated stress levels reported by HC users versus NC women.
"The present data are the first that we know of to characterize psychological and in vivo biological responses to an acute social stressor in both NC and HC-using women," the authors write. "Future research is needed to investigate the mechanisms underlying these interactions and to translate these findings into improved mental and physical health for the millions of women who use HCs."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Active Surveillance Effective Strategy for Favorable-Risk Prostate Cancer
FRIDAY, May 31, 2024 -- Active surveillance is an effective management strategy for men with favorable-risk prostate cancer, with an estimated rate of metastasis of 1.4 percent at...
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.